Outpace Bio
PrivateLast Round
Series B
Aug 1, 2024
Total Funding Raised
$174M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Outpace Bio is a biotechnology company that develops AI-powered protein design technologies to engineer immune cells for more effective and safer cell therapies targeting solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Outpace Bio Comparables
Compare Outpace Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArsenalBio | 78% | |
| LabGenius Therapeutics | 74% | |
| Evozyne | 73% | |
Outpace Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 1, 2024 | ||||
| Series A | Mar 31, 2021 |
Key People
Founding team and executive leadership
Outpace Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| RA Capital Management | Series B |
| WRF Capital | Series A, Series B |
| Playground Global | Series A, Series B |
| ARTIS Ventures | Series B, Series A |
| Washington Research Foundation Capital | Series A, Series B |
| Abstract Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 40% MoM.
- Nov 4, 2025
Lead candidate OPB-101 targeting ovarian cancer to begin dosing in 2025.
Outpace Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Outpace Bio's valuation, stock price, and market status.